​

Aura Biosciences Ownership | Who Owns Aura Biosciences?


OverviewForecastFinancialsChart

Aura Biosciences Ownership Summary


Aura Biosciences is owned by 141.67% institutional investors, 1.18% insiders. Tcg crossover management is the largest institutional shareholder, holding 14.13% of AURA shares. Eventide Healthcare & Life Sciences I is the top mutual fund, with 8.16% of its assets in Aura Biosciences shares.

AURA Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAura Biosciences141.67%1.18%-42.86%
SectorHealthcare Stocks 245.07%12.10%-157.17%
IndustryBiotech Stocks 380.48%11.73%-292.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Tcg crossover management9.53M14.13%$67.69M
Matrix capital management company, lp6.92M11.47%$46.31M
Suvretta capital management7.21M10.68%$51.16M
Frazier life sciences management7.10M10.53%$50.41M
Long focus capital management5.12M7.59%$36.35M
Blackrock funding, inc. /de4.71M6.98%$33.42M
Adage capital partners gp4.64M6.88%$32.94M
Caligan partners lp4.30M6.37%$30.52M
Vanguard capital management4.10M6.08%$29.11M
Blackrock3.01M6.08%$22.72M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Matrix capital management company, lp6.92M100.00%$46.31M
Medicxi ventures management (jersey)3.04M12.16%$21.58M
Fcpm iii services b.v.4.05M3.84%$28.78M
B group764.24K2.55%$5.43M
Acorn capital advisors929.08K1.80%$6.60M
Tcg crossover management9.53M1.63%$67.69M
Regency capital management inc.\de540.39K1.53%$3.84M
Foresite capital management vi1.33M1.47%$9.47M
Caligan partners lp4.30M1.44%$30.52M
Frazier life sciences management7.10M1.10%$50.41M

Top Buyers

HolderShares% AssetsChange
Tcg crossover management9.53M1.63%9.53M
Caligan partners lp4.30M1.44%4.07M
Fcpm iii services b.v.4.05M3.84%4.05M
Orbimed advisors3.33M0.44%3.33M
Suvretta capital management7.21M0.94%2.83M

Top Sellers

HolderShares% AssetsChange
Eventide asset management---4.08M
Millennium management617.47K0.00%-480.16K
Samsara biocapital584.85K0.47%-415.15K
Ensign peak advisors---390.69K
Decheng capital---360.48K

New Positions

HolderShares% AssetsChangeValue
Tcg crossover management9.53M1.63%9.53M$67.69M
Fcpm iii services b.v.4.05M3.84%4.05M$28.78M
Orbimed advisors3.33M0.44%3.33M$23.67M
Ra capital management2.50M0.15%2.50M$17.75M
Redmile group1.67M0.79%1.67M$11.83M

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-4.00
Advisory services network-6.00
Root financial partners-7.00
Mai capital management-16.00
Capital performance advisors llp-25.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202614917.32%95,555,89987.80%1411.99%9652.38%28-30.00%
Mar 31, 202653-54.31%8,140,896-83.79%130.23%29-44.23%15-60.53%
Dec 31, 202576-28.30%32,618,162-36.85%490.62%32-40.74%2827.27%
Sep 30, 20251037.29%51,053,7131.75%871.18%53-1.85%21-25.00%
Jun 30, 20251018.60%50,603,53553.66%872.02%5732.56%29-3.33%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Eventide Healthcare & Life Sciences I4.08M8.16%-1.72M
Vanguard MStar Total Stk Mkt Idx Invest2.96M3.06%57.13K
Vanguard Morn Total Stk Mkt Idx Investor2.90M2.81%141.60K
Vanguard Total Stock Mkt Idx Inv2.90M2.81%141.60K
Franklin Biotechnology Discv A(acc)USD1.31M1.35%-
Vanguard Institutional Extnd Mkt Idx Tr1.13M1.18%26.73K
iShares Russell 2000 ETF1.15M1.11%-20.35K
Franklin Biotechnology Discovery A765.62K0.79%-
Fidelity Extended Market Index497.13K0.48%-5.27K
iShares Biotechnology ETF469.81K0.45%-1.43K

Recent Insider Transactions


DateNameRoleActivityValue
Jun 16, 2026Gibney Anthony S See RemarksSell$82.33K
May 07, 2026Matrix Capital Management Company, LP-Sell$39.04M
Apr 16, 2026Kilroy Conor See RemarksSell$82.40K
Feb 17, 2026Kilroy Conor See RemarksSell$61.00K
Feb 17, 2026Plavsic Mark Chief Technology OfficerSell$80.24K

Insider Transactions Trends


DateBuySell
2026 Q3--
2026 Q2-3
2026 Q1-7
2025 Q4-4
2025 Q3-1

AURA Ownership FAQ


Who Owns Aura Biosciences?

Aura Biosciences shareholders are primarily institutional investors at 141.67%, followed by 1.18% insiders and -42.85% retail investors. The average institutional ownership in Aura Biosciences's industry, Biotech Stocks , is 380.48%, which Aura Biosciences falls below.

Who owns the most shares of Aura Biosciences?

Aura Biosciences’s largest shareholders are Tcg crossover management (9.53M shares, 14.13%), Matrix capital management company, lp (6.92M shares, 11.47%), and Suvretta capital management (7.21M shares, 10.68%). Together, they hold 36.29% of Aura Biosciences’s total shares outstanding.

Does Blackrock own Aura Biosciences?

Yes, BlackRock owns 6.08% of Aura Biosciences, totaling 3.01M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 22.72M$. In the last quarter, BlackRock increased its holdings by 560.52K shares, a 22.93% change.

Who is Aura Biosciences’s biggest shareholder by percentage of total assets invested?

Matrix capital management company, lp is Aura Biosciences’s biggest shareholder by percentage of total assets invested, with 100.00% of its assets in 6.92M Aura Biosciences shares, valued at 46.31M$.

Who is the top mutual fund holder of Aura Biosciences shares?

Eventide Healthcare & Life Sciences I is the top mutual fund holder of Aura Biosciences shares, with 8.16% of its total shares outstanding invested in 4.08M Aura Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools